Figure 4From: Modulating co-stimulation: a rational strategy in the treatment of rheumatoid arthritis?Interfering at an early stage in an immune response (i.e. T cell activation) is likely to block subsequent inflammatory events mediated by several different effector cells. APC, antigen-presenting cell; IL, interleukin; TNF, tumour necrosis factor.Back to article page